UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international Phase I/II clinical trial led ...

Editing CAR T cells to produce inflammatory cytokines helps them enter solid tumors and promote cancer killing.

CAR T-cell therapy has the potential to revolutionise how we treat certain types of cancer by genetically engineering someone’s own immune cells to attack the disease – but it is also cumbersome and ...

Killer immune cells destroy cancer cells and cells infected by virus. These CD8 + T cells are activated after detection of viral infection or growth of “non-self” tumor cells. However, in chronic ...

Researchers at MIT and Stanford University have developed a new way to stimulate the immune system to attack tumor cells, ...

Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international phase 1/2 clinical trial led ...

Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...